March 25, 2025 08:57 PM EDTUpdated 09:10 PM

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

Zachary Brennan

Senior Editor

The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Makary as FDA commissioner, putting him in charge of the agency amid ongoing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Lyndra Therapeutics to wind down amid funding hurdles for long-acting drug technology

WuXi Biologics’ licensing deals help offset Biosecure threat in the US

Eisai cuts Leqembi 2027 sales forecast by half but expects 'continued growth'

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

GSK scores FDA approval for antibiotic to treat uncomplicated UTIs

Senate committee backs Dr. Oz's nomination to lead CMS

Sen­ate con­firms Makary as FDA chief with agency cuts, re­turn-to-of­fice in force

Zachary Brennan

Senior Editor

Sign up to read this article for free.

more like this

Lyn­dra Ther­a­peu­tics to wind down amid fund­ing hur­dles for long-act­ing drug tech­nol­o­gy

WuXi Bi­o­log­ics’ li­cens­ing deals help off­set Biose­cure threat in the US

Ei­sai cuts Leqem­bi 2027 sales fore­cast by half but ex­pects 'con­tin­ued growth'

Mer­ck strikes deal for heart drug, worth up to $2B, with Chi­na’s Hen­grui

GSK scores FDA ap­proval for an­tibi­ot­ic to treat un­com­pli­cat­ed UTIs

Sen­ate com­mit­tee backs Dr. Oz's nom­i­na­tion to lead CMS

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

Lyndra Therapeutics to wind down amid funding hurdles for long-acting drug technology

WuXi Biologics’ licensing deals help offset Biosecure threat in the US

Eisai cuts Leqembi 2027 sales forecast by half but expects 'continued growth'

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

GSK scores FDA approval for antibiotic to treat uncomplicated UTIs

Senate committee backs Dr. Oz's nomination to lead CMS